Hylenex Articles
Halozyme gets $5.5M Baxter payment
12 January 2009
Hylenex may have role in analgesia, says trial
26 February 2007
Stock Commentary - New York week to Feb 13, 2006
20 February 2006
Baxter/Halozyme see good data on SubQ plus Hylenex
20 February 2006
Peregrine unit begins first commercial-stage project
12 December 2005
Halozyme/Baxter get FDA appro for Hylenex
12 December 2005
Halozyme/Baxter sign EU Hylenex deal
15 August 2005
Halozyme's Hylenex NDA accepted by FDA
6 June 2005
Showing 1-9 of 9 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
